Adults with type 2 diabetes and overweight or obesity who use a GLP-1 receptor agonist have similar risk for kidney cancer as those using an SGLT2 inhibitor, according to findings from a target trial emulation
Private consultation rooms where you can discuss sensitive topics comfortably Clean, professional spaces that feel more spa-like than hospital-like Staff who remember your name and your specific goals Flexible scheduling that respects your time These details might seem small, but they create an atmosphere where you actually want to show up for appointments and stay committed to your program
Proper nutrition also works together with the medication to enhance weight loss effects
Semaglutide was first made for people with type 2 diabetes, but now it's also used by people who just want to lose weight even if they don't have diabetes
For patients seeking an acute shift, whether for cognitive clarity, recovery, or performance, the IV route is meaningfully different from oral supplementation
A new study is raising concerns about GLP-1 weight loss drugs and eating disorders